Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 314101 - 314120 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Lithuania | (L01EL01) ibrutinib (adm: O) | IMBRUVICA 140 mg kietosios kapsulės N120 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01EL01) ibrutinib (adm: O) | IMBRUVICA 140 mg kietosios kapsulės N90 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01EL01) ibrutinib (adm: O) | Imbruvica 140 mg plėvele dengtos tabletės N30x1 (Janssen-Cilag International N.V., Belgija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01EL01) ibrutinib (adm: O) | Imbruvica 140 mg plėvele dengtos tabletės N30x1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01EL01) ibrutinib (adm: O) | Imbruvica 420 mg plėvele dengtos tabletės N30x1 (Janssen-Cilag International N.V., Belgija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01EL01) ibrutinib (adm: O) | Imbruvica 420 mg plėvele dengtos tabletės N30x1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01EL01) ibrutinib (adm: O) | Imbruvica 560 mg plėvele dengtos tabletės N30x1 (Janssen-Cilag International N.V., Belgija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01EL01) ibrutinib (adm: O) | Imbruvica 560 mg plėvele dengtos tabletės N30x1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01EL02) acalabrutinib (adm: O) | Calquence 100 mg kietosios kapsulės N60 (AstraZeneca AB, Švedija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | AstraZenecaAB,Švedija |
| Lithuania | (L01EL02) acalabrutinib (adm: O) | Calquence 100 mg plėvele dengtos tabletės N60 (AstraZeneca AB, Švedija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | AstraZenecaAB,Švedija |
| Lithuania | (L01EL02) acalabrutinib (adm: O) | Calquence 100 mg plėvele dengtos tabletės N60 (AstraZeneca AB, Švedija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | AstraZenecaAB,Švedija |
| Lithuania | (L01EN02) pemigatinib (adm: O) | Pemazyre 13,5 mg tabletės N14 (Incyte Biosciences Distribution B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteBiosciencesDistributionB.V.,Nyderlandai |
| Lithuania | (L01EN02) pemigatinib (adm: O) | Pemazyre 4,5 mg tabletės N14 (Incyte Biosciences Distribution B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteBiosciencesDistributionB.V.,Nyderlandai |
| Lithuania | (L01EN02) pemigatinib (adm: O) | Pemazyre 9 mg tabletės N14 (Incyte Biosciences Distribution B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteBiosciencesDistributionB.V.,Nyderlandai |
| Lithuania | (L01EX01) sunitinib (adm: O) | Klertis 12,5 mg kietosios kapsulės N28 (EGIS Pharmaceuticals PLC, Vengrija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EGISPharmaceuticalsPLC,Vengrija |
| Lithuania | (L01EX01) sunitinib (adm: O) | Klertis 12,5 mg kietosios kapsulės N28 (EGIS Pharmaceuticals PLC, Vengrija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | EGISPharmaceuticalsPLC,Vengrija |
| Lithuania | (L01EX01) sunitinib (adm: O) | Sunitinib Accord 12,5 mg kietosios kapsulės N28 (Accord Healthcare S.L.U., Ispanija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01EX01) sunitinib (adm: O) | Sunitinib Accord 12,5 mg kietosios kapsulės N28x1 (Accord Healthcare S.L.U., Ispanija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01EX01) sunitinib (adm: O) | Sunitinib G.L. Pharma 12,5 mg kietosios kapsulės N30 (G.L. Pharma GmbH, Austrija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | G.L.PharmaGmbH,Austrija |
| Lithuania | (L01EX01) sunitinib (adm: O) | Sunitinib Sandoz 12,5 mg kietosios kapsulės N28 (Sandoz d.d., Slovėnija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sandozd.d.,Slovėnija |
Pages
